Filter Results:
(1,140)
Show Results For
- All HBS Web
(1,140)
- People (1)
- News (317)
- Research (693)
- Events (5)
- Multimedia (14)
- Faculty Publications (403)
Show Results For
- All HBS Web
(1,140)
- People (1)
- News (317)
- Research (693)
- Events (5)
- Multimedia (14)
- Faculty Publications (403)
- 06 Mar 2006
- Research & Ideas
Winners and Losers at the Olympics
Speaking of Beijing, Cisco, Google, Microsoft, and Yahoo have recently garnered some negative headlines for concessions they made to do business in China. As companies plan their marketing campaigns for the Summer Olympics there, what do... View Details
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
Might Also Like: The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations Buy-In from Black Patients Suffers When Drug View Details
- 17 Nov 2016
- Op-Ed
What's Behind the Unexpected Trump Support from Women
higher education His stand on workplace deregulation raises concerns about continued protection of women’s (and men’s) human and civil rights A reshaped Supreme Court could roll back protections to the... View Details
Keywords: by Laura Morgan Roberts and Robin Ely
- 2024
- Working Paper
Do Information Frictions and Corruption Perceptions Kill Competition? A Field Experiment on Public Procurement in Uganda
By: Emanuele Colonnelli, Francesco Loiacono, Edwin Muhumuza and Edoardo Teso
We study whether information frictions and corruption perceptions deter firms from doing business with the government. We conduct two nationwide randomized controlled trials (RCTs) in collaboration with the national public procurement supervisory and anti-corruption... View Details
Keywords: Knowledge Use and Leverage; Government and Politics; Crime and Corruption; Trust; Perception; Business and Government Relations
Colonnelli, Emanuele, Francesco Loiacono, Edwin Muhumuza, and Edoardo Teso. "Do Information Frictions and Corruption Perceptions Kill Competition? A Field Experiment on Public Procurement in Uganda." NBER Working Paper Series, No. 32170, February 2024.
- 21 Nov 2013
- News
Case Study: BlackBerry and Thorsten Heins
status quo, and focus on elaborate plans and execution infrastructures, in an environment more suited to trial and error learning. Ultimately,... View Details
- 2023
- Working Paper
Life After Death: A Field Experiment with Small Businesses on Information Frictions, Stigma, and Bankruptcy
By: Shai Benjamin Bernstein, Emanuele Colonnelli, Mitchell Hoffman and Benjamin Iverson
In a randomized control trial (RCT) with U.S. small businesses, we document that a large share of firms are not well-informed about bankruptcy. Many assume that bankruptcy necessarily entails the death of a business and do not know about Chapter 11 bankruptcy, where... View Details
Bernstein, Shai Benjamin, Emanuele Colonnelli, Mitchell Hoffman, and Benjamin Iverson. "Life After Death: A Field Experiment with Small Businesses on Information Frictions, Stigma, and Bankruptcy." NBER Working Paper Series, No. 30933, February 2023.
- 12 Jun 2018
- First Look
New Research and Ideas, June 12, 2018
forthcoming Cambridge, MA: Harvard University Press The Academy of Fisticuffs: Political Economy and Commercial Society in Enlightenment Italy By: Reinert, Sophus A. Abstract—The terms “capitalism” and... View Details
Keywords: Dina Gerdeman
- Summer 2015
- Article
The Effect of Delaware Doctrine on Freezeout Structure and Outcomes: Evidence on the Unified Approach
By: Fernan Restrepo and Guhan Subramanian
Historically, Delaware corporate law provided different standards of judicial review for buyouts by controlling shareholders (also known as "freezeouts") based on what transactional form was used: deferential business judgment review for freezeouts executed as tender... View Details
Restrepo, Fernan, and Guhan Subramanian. "The Effect of Delaware Doctrine on Freezeout Structure and Outcomes: Evidence on the Unified Approach." Harvard Business Law Review 5, no. 2 (Summer 2015): 205–236.
- 14 Nov 2017
- First Look
New Research and Ideas: November 14, 2017
experts to discuss how researchers can impact a broader audience, by lending their scientific expertise to pressing social issues, current events, and public debates. The landmark Brown v. Board of Education case, in which the Supreme... View Details
Keywords: Carmen Nobel
- 01 Dec 2020
- News
New Releases: Alumni and Faculty Books
you could learn from rejection. In Spring, he puts a gentle arm around your shoulders and helps you bounce back stronger than ever from every rejection. Juror Number Two By Efrem Sigel (MBA 1968) The Writers Press This riveting memoir... View Details
Keywords: Margie Kelley
- March 2012 (Revised October 2013)
- Supplement
Gene Patents (B)
By: Richard Hamermesh and Phillip Andrews
The case updates events since the Court's ruling against Myriad Genetics on March 29, 2010 and should be used in conjunction with Gene Patents (A). On July 29, 2011, a US Appeals Court reversed the prior ruling against Myriad. On September 16, 2011, the first major... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Investment; Biotechnology Industry; United States
Hamermesh, Richard, and Phillip Andrews. "Gene Patents (B)." Harvard Business School Supplement 812-130, March 2012. (Revised October 2013.)
- March 1991 (Revised July 2001)
- Supplement
Ann Hopkins (B)
By: Joseph L. Badaracco Jr. and Ilyse Barkan
Describes the reasons why the courts found in favor of Ann Hopkins in the sexual discrimination suit. Also explains why the courts concluded she was the victim of sexual stereotyping. View Details
Badaracco, Joseph L., Jr., and Ilyse Barkan. "Ann Hopkins (B)." Harvard Business School Supplement 391-170, March 1991. (Revised July 2001.)
- September 1984 (Revised July 2005)
- Case
Higgins v. Commissioner
By: Henry B. Reiling
Discusses the issue of whether an activity is a trade or business. The Court held that the taxpayer's very substantial stock and bond portfolio management activities were not a trade or business, whereas the taxpayer's real estate activities did constitute a trade or... View Details
Reiling, Henry B. "Higgins v. Commissioner." Harvard Business School Case 285-008, September 1984. (Revised July 2005.)
- 08 Mar 2019
- Research & Ideas
Seven Negotiation Lessons from Amazon's HQ Disaster in Queens
negotiating too narrowly with those who have formal power and authority. Negotiation experts have a patriarchal name for a version of this classic—and avoidable—mistake: Decide-Announce-Defend or DAD. Along with gaining the full-throated... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
forthcoming World Happiness Report Happiness and Prosocial Behavior: An Evaluation of the Evidence By: Aknin, Lara B., A.V. Whillans, Michael I. Norton, and Elizabeth W. Dunn Abstract— Humans are an... View Details
Keywords: Dina Gerdeman
- 01 Jun 2018
- News
June 2018 Alumni and Faculty Books
a rising corporate attorney, was charged with murdering his lover, also a rising advertising executive in Manhattan. The dramatic trial that followed this incident played out for several years, mirroring the loss of sensibility to crime,... View Details
- 10 Jul 2018
- First Look
New Research and Ideas, July 10, 2018
business plans, and key personnel ignited a bi-coastal battle between two fierce rivals that was played out in courts competing for jurisdiction and states with diametrically... View Details
Keywords: Dina Gerdeman
- 2023
- Working Paper
Market Exclusivity and Innovation: Evidence From Antibiotics
By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Kong, Edward, and Olivia Zhao. "Market Exclusivity and Innovation: Evidence From Antibiotics." Working Paper, December 2023.